Insider · CIK 0001846625
Daniel Alexander Yerace
Files at ZSQR (Coeptis Therapeutics Holdings, Inc.). First filing Jan 9, 2024, latest Jan 9, 2024.
In brief
Daniel Alexander Yerace files SEC Form 4 as officer and director at ZSQR (Coeptis Therapeutics Holdings, Inc.). Since Jan 9, 2024, Daniel Alexander Yerace has reported 1 open-market buy worth $7,487 and 0 open-market sells worth $0, the latest filed on Jan 9, 2024.
A track record needs three past buys with six months of prices behind them; Daniel Alexander Yerace has 0, so none is measured yet.
The newest scored trade: bought $7,487 of ZSQR on Jan 5, 2024, filed Jan 9, 2024, scored 48 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ZSQR: Coeptis Therapeutics Holdings, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | Coeptis Therapeutics Holdings, Inc. | $7,487 10,850 shares | +1% | +1% from low-68% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Apr 16, 2026 | ZSQR Coeptis Therapeutics Holdings, Inc. | 5,000 0.08% of outstanding | $64k | Apr 16, 2026 | none |
| Dec 15, 2025 | ZSQR Coeptis Therapeutics Holdings, Inc. | 5,000 0.03% of outstanding | $75k | Dec 15, 2025 | none |
| Sep 2, 2025 | ZSQR Coeptis Therapeutics Holdings, Inc. | 5,000 0.10% of outstanding | $65k | Sep 2, 2025 | none |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | ZSQR Coeptis Therapeutics Holdings, Inc. | MOption exercise Common stock | +10,000 | $10.41 | $104k | 70,531 | Feb 13, 2026 |
| Feb 11, 2026 | ZSQR Coeptis Therapeutics Holdings, Inc. | AGrant or award Common Stock | +20,000 | $0.00 | $0 | 70,531 | Feb 13, 2026 |
| Mar 4, 2025 | ZSQR Coeptis Therapeutics Holdings, Inc. | AGrant or award Non-Qualified Stock Options (right to buy)derivative | +5,000 | - | - | 25,000 | Mar 6, 2025 |
| Jan 5, 2024 | ZSQR Coeptis Therapeutics Holdings, Inc. | POpen-market purchase Common Stock | +10,850 | $0.69 | $7,487 | 1,071,455 | Jan 9, 2024 |
Questions about Daniel Alexander Yerace
Answered from the filings on this page, as of the latest one.
Is Daniel Alexander Yerace buying or selling?
Not in the last 12 months. Daniel Alexander Yerace's latest open-market trade on SEC Form 4 was bought $7,487 of ZSQR on Jan 5, 2024.
How did Daniel Alexander Yerace's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Daniel Alexander Yerace has 0.
Where does Daniel Alexander Yerace file Form 4?
Daniel Alexander Yerace has filed Form 4 at ZSQR (Coeptis Therapeutics Holdings, Inc.) as VP of Operations. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.